Loading…

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study

Little is known about whether tolerability and adherence to treatment can be influenced by weather and temperature conditions. The objective of this study was to assess monthly and seasonal adherence to and safety of sc IFN-β1a (Rebif®, Merck) in relapsing-remitting multiple sclerosis (RRMS) patient...

Full description

Saved in:
Bibliographic Details
Published in:BMC neurology 2018-11, Vol.18 (1), p.186-186, Article 186
Main Authors: Deftereos, Spyros N, Koutlas, Evangelos, Koutsouraki, Efrosini, Kyritsis, Athanassios, Papathanassopoulos, Panagiotis, Fakas, Nikolaos, Tsimourtou, Vaia, Vlaikidis, Nikolaos, Tavernarakis, Antonios, Voumvourakis, Konstantinos, Arvanitis, Michalis, Sakellariou, Dimitrios, DeLorenzo, Filippo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Little is known about whether tolerability and adherence to treatment can be influenced by weather and temperature conditions. The objective of this study was to assess monthly and seasonal adherence to and safety of sc IFN-β1a (Rebif®, Merck) in relapsing-remitting multiple sclerosis (RRMS) patients using the RebiSmart® electronic autoinjector. A multicentre, prospective observational study in Greece in adult RRMS patients with EDSS
ISSN:1471-2377
1471-2377
DOI:10.1186/s12883-018-1179-0